ITMI921930A1 - Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda - Google Patents
Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevandaInfo
- Publication number
- ITMI921930A1 ITMI921930A1 IT001930A ITMI921930A ITMI921930A1 IT MI921930 A1 ITMI921930 A1 IT MI921930A1 IT 001930 A IT001930 A IT 001930A IT MI921930 A ITMI921930 A IT MI921930A IT MI921930 A1 ITMI921930 A1 IT MI921930A1
- Authority
- IT
- Italy
- Prior art keywords
- dihydropyridins
- drink
- pharmaceutical compositions
- oral administration
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI921930A IT1255792B (it) | 1992-08-05 | 1992-08-05 | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda |
| EP93111920A EP0582169A3 (en) | 1992-08-05 | 1993-07-26 | Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| US08/099,288 US5491154A (en) | 1992-08-05 | 1993-07-29 | Pharmaceutical preparation for the oral administration of dihydropyridines |
| CA002101680A CA2101680A1 (en) | 1992-08-05 | 1993-07-30 | Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
| JP5209968A JPH072700A (ja) | 1992-08-05 | 1993-08-03 | ジヒドロピリジンの飲料の形態の経口投与用製薬学的組成物 |
| US08/536,552 US5622978A (en) | 1992-08-05 | 1995-09-29 | Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI921930A IT1255792B (it) | 1992-08-05 | 1992-08-05 | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITMI921930A0 ITMI921930A0 (it) | 1992-08-05 |
| ITMI921930A1 true ITMI921930A1 (it) | 1994-02-05 |
| IT1255792B IT1255792B (it) | 1995-11-16 |
Family
ID=11363839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI921930A IT1255792B (it) | 1992-08-05 | 1992-08-05 | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5491154A (it) |
| EP (1) | EP0582169A3 (it) |
| JP (1) | JPH072700A (it) |
| CA (1) | CA2101680A1 (it) |
| IT (1) | IT1255792B (it) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US6726930B1 (en) | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
| EP0859603B1 (en) | 1996-07-08 | 2008-12-17 | Penwest Pharmaceuticals Co. | Sustained release matrix for high-dose insoluble drugs |
| US5891469A (en) * | 1997-04-02 | 1999-04-06 | Pharmos Corporation | Solid Coprecipitates for enhanced bioavailability of lipophilic substances |
| WO1998008490A1 (en) * | 1996-09-01 | 1998-03-05 | Pharmos Corporation | Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| US6056977A (en) | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
| GB9920558D0 (en) * | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
| MXPA01005370A (es) | 1999-09-30 | 2004-05-14 | Penwest Pharmaceuticals Co | Sistema de matriz de liberacion sostenida para farmacos altamente solubles. |
| IL134701A0 (en) * | 2000-02-23 | 2001-04-30 | J P M E D Ltd | Homogeneous solid matrix containing vegetable proteins |
| US6589955B2 (en) | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| EP1401399A2 (en) * | 2001-06-22 | 2004-03-31 | Pfizer Products Inc. | Pharmaceutical compositions containing polymer and drug assemblies |
| US20040185110A1 (en) * | 2002-11-08 | 2004-09-23 | Ronald Harland | Formulations of low solubility bioactive agents and processes for making the same |
| BRPI0412190A (pt) * | 2003-07-01 | 2006-08-22 | Pharmacia & Upjohn Co Llc | sólidos com camada de difusão modulada |
| US7507823B2 (en) * | 2004-05-06 | 2009-03-24 | Bristol-Myers Squibb Company | Process of making aripiprazole particles |
| TR201100152A2 (tr) * | 2011-01-06 | 2012-07-23 | Bi̇lgi̇ç Mahmut | Amlodipin içeren efervesan bileşimler. |
| US9399019B2 (en) | 2012-05-09 | 2016-07-26 | Evonik Corporation | Polymorph compositions, methods of making, and uses thereof |
| CN105596293A (zh) * | 2016-01-29 | 2016-05-25 | 中国药科大学 | 一种脑靶向尼莫地平纳米混悬剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
| DE1962791A1 (de) * | 1969-12-15 | 1971-06-24 | Boehringer Mannheim Gmbh | Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben |
| US4154839A (en) * | 1975-11-05 | 1979-05-15 | Bayer Aktiengesellschaft | 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine |
| EP0001247A1 (en) * | 1977-09-14 | 1979-04-04 | Kanebo, Ltd. | Pharmaceutical preparation containing nifedipine and a method for producing the same. |
| DE2815578C2 (de) * | 1978-04-11 | 1986-01-16 | Bayer Ag, 5090 Leverkusen | Neue pharmazeutische Verwendung von Nimodipin |
| JPH0729926B2 (ja) * | 1989-07-25 | 1995-04-05 | 大塚製薬株式会社 | 易吸収性製剤用組成物 |
| GB9025251D0 (en) * | 1990-11-20 | 1991-01-02 | Solomon Montague C | Nifedipine dosage forms |
-
1992
- 1992-08-05 IT ITMI921930A patent/IT1255792B/it active IP Right Grant
-
1993
- 1993-07-26 EP EP93111920A patent/EP0582169A3/de not_active Withdrawn
- 1993-07-29 US US08/099,288 patent/US5491154A/en not_active Expired - Fee Related
- 1993-07-30 CA CA002101680A patent/CA2101680A1/en not_active Abandoned
- 1993-08-03 JP JP5209968A patent/JPH072700A/ja active Pending
-
1995
- 1995-09-29 US US08/536,552 patent/US5622978A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI921930A0 (it) | 1992-08-05 |
| US5491154A (en) | 1996-02-13 |
| CA2101680A1 (en) | 1994-02-06 |
| IT1255792B (it) | 1995-11-16 |
| JPH072700A (ja) | 1995-01-06 |
| US5622978A (en) | 1997-04-22 |
| EP0582169A2 (de) | 1994-02-09 |
| EP0582169A3 (en) | 1995-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI921930A1 (it) | Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda | |
| ITMI911149A0 (it) | Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale | |
| NO943761L (no) | Oralt administrerbare opioide formuleringer med forlenget effektvarighet | |
| ITBO910024A0 (it) | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale | |
| IT1177152B (it) | Procedimento e composizione per la preparazione di prodotti farmaceutici ad azione prolungata controllata per la somministrazione orale | |
| IT1184653B (it) | Preparato a forma di foglio per la somministrazione di prodotti nella cavita' orale | |
| IL115097A0 (en) | Pharmaceutical compositions adapted for oral administration | |
| ATE219377T1 (de) | Neue galenische orale pharmazeutische formulierung | |
| DE4291156T1 (de) | Verbesserte pharmazeutische Zusammensetzungen | |
| FI950947L (fi) | Oraalisesti annettavat farmaseuttiset formulaatiot | |
| EP0652770A4 (en) | ORAL GIVING OF ANTIGENS. | |
| ITMI930605A1 (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| FI910088A7 (fi) | Oraalinen farmaseuttinen koostumus | |
| NO950134D0 (no) | Formuleringer for oralt administrerte farmasöytiske midler | |
| ITTO920303A0 (it) | "composizione farmaceutica antiinfiammatoria" | |
| IT9019112A1 (it) | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina | |
| MX9203615A (es) | Composicion farmaceutica en forma de polvo para administracion nasal. | |
| IT1234194B (it) | Composizioni farmaceutiche in forma di sciroppo contenenti pentitoli quali agenti di veicolazione | |
| IT9021021A0 (it) | Composizioni farmaceutiche per la somministrazione orale di irudina | |
| FI952377A7 (fi) | Farmaseuttisia ibuprofeenikoostumuksia | |
| ITMI911445A1 (it) | Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva | |
| FI934387A7 (fi) | 3-substituoituja 2-oksi-indoli-1-karboksiamidia käsittäviä farmaseuttisia koostumuksia | |
| ITMI913510A1 (it) | Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita' | |
| IT8219012A0 (it) | Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche. | |
| ITRM920535A0 (it) | Composizione farmaceutica per la somministrazione attraverso le mucose. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970827 |